1163286

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

February 18, 2022

Fiscal Year

2022

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Philadelphia, PA (United States)

Additional Details